Achira Labs logo

About Achira Labs

Pioneering frictionless, point-of-care testing to bridge the gap between clinical labs and patient needs.

Our Story

Founded in 2009 in Bengaluru, India, Achira Labs began with a vision to decentralize medical diagnostics. We recognized that while central labs offer precision, they often lack speed and accessibility for patients in need of immediate care.

By leveraging proprietary microfluidics and hydrogel technology, we have developed platforms that shrink the lab onto a chip. Today, we are an ISO 13485 compliant company, transforming how diagnostics are delivered across India and beyond.

Our Mission

To empower patients and doctors with convenient, timely access to affordable and accurate medical testing.

Accessibility

We believe geography should not dictate health outcomes. Our portable platforms bring sophisticated testing to clinics, small labs, and remote settings.

Accuracy

We do not compromise on quality for speed. Our microfluidic technology ensures lab-grade precision in a rapid format.

Empowerment

By providing immediate quantitative results, we empower clinicians to make informed treatment decisions on the spot, reducing anxiety and improving care.

Our Vision

A world where advanced medical diagnostics are not a luxury, but a standard of care available to everyone. We aim to be a global leader in point-of-care testing by continuously innovating at the intersection of biology, engineering, and connected health.

Investors & Funders

We are proud to collaborate with leading organizations to advance healthcare access.

  • Cipla
  • Catamaran
  • Nadathur
  • Gates Foundation
  • Grand Challenges Canada
  • BIRAC
  • C-CAMP
  • ICMR
  • ICARS
  • IGSTC

Partners & Collaborators

  • Indian Institute of Science
  • NITK Surathkal
  • C-Camp
  • BI Flow Systems
  • IIT Hyderabad
  • MIT - Massachusetts Institute of Technology
  • GenePath Dx
  • Padmashree College of Hospital Administration
  • Cloudnine
  • Anand Neuberg
  • Avay Biosciences

Collaborate with our R&D team.

Contact Us

Intellectual Property & Publications

Pioneering research backed by a robust portfolio of patents and peer-reviewed studies.

Granted Patents

Patent Number Title
US 8,647,742 Diagnostic gel composition, method for making a diagnostic gel composition
US 9,714,912 B2 Compositions for fabric based lateral flow assay device using electrochemical detection means
CN 102811815 B Method for making and using a diagnostic element
JP 5661795 B2 Diagnostic Element, and a diagnostic device comprising a diagnostic element
US 2018/0072987 A1 Method for extracting viable sperms from a seme.n sample (USelect Technology)
JP 5775157 B2 Methods of making a diagnostic device by interweaving hydrophobic and hydrophilic fibers

Key Scientific Publications

The Quantitative Detection of Cystatin-C in Patient Samples Using a Colorimetric Lateral Flow Immunoassay

Santosh Kumar Bikkarolla et al. (2024)

A collaborative effort with Vision Research Foundation Chennai, validating our QuantALFA™ platform for renal function testing.

A hydrogel sensor-based microfluidic platform for the quantitative and multiplexed detection of fertility markers

Anal Methods, 2019, 11, 1639-1650

Describes the core technology behind our μFluidix Fertility Panel, demonstrating high sensitivity for point-of-care immunoassays.

Woven electrochemical fabric-based test sensors (WEFTS): a new class of multiplexed electrochemical sensors

Lab on a Chip, 2015, 15, 2064-2072

Explores our innovative "Lab-on-Fabric" technology for creating low-cost, multiplexed sensors.

Wearable Woven Electrochemical Biosensor Patch for Non‐invasive Diagnostics

Electroanalysis, 2016, Volume 28, Issue 6

Research into non-invasive diagnostic solutions using wearable textile sensors.

'Fab-chips': a versatile, fabric-based platform for low-cost, rapid and multiplexed diagnostics

Lab on a Chip, 2011, 11, 2493-2499

Foundational paper establishing the viability of fabric-based microfluidics for rapid diagnostics.

Discontinued commercially

Fabric Technology

Achira has developed a revolutionary new fabric-based technology to perform lateral flow and electrochemical assays. Using our patented approach, yarn coated with reagents is woven into fabric that can be cut into strips to make individual or multiplexed test sensors.

The inherent scalability of the textile manufacturing process leads to significant cost savings. This platform lends itself easily to low-resource settings, with the potential to use local skills and networks for assembly.

Electrochemical Sensors

Yarns pre-coated with conducting inks and reagents are woven to mass-manufacture sensors in a single step, offering a lower-cost alternative to screen printing.

Immunosensors

Lateral-flow immunosensors built on fabric. The entire assembly—conjugate reagents, test lines, and control lines—is assembled in one step on a loom.

Weaving Health & Livelihood

"Achira has partnered with community organizations to weave and assemble diagnostic strips at the point of care, generating employment and increasing local availability of tests."

Social Innovation

Want to learn more about our work?

Get in Touch